Generic Drugs: ‘Competitive’ Exclusivity Benefited Few Sponsors But Is Increasingly Popular

 
• By Derrick Gingery
leading competition
Twelve CGT approvals have seen follow-on competition approved just after exclusivity expired, suggesting an advantage to the designation. • Source: Alamy

More from Generics

More from Biosimilars & Generics